These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 34430453)

  • 41. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
    Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis.
    Makunde WH; Kamugisha LM; Massaga JJ; Makunde RW; Savael ZX; Akida J; Salum FM; Taylor MJ
    Filaria J; 2003 Nov; 2(1):15. PubMed ID: 14613509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event.
    Sanz-Navarro J; Feal C; Dauden E
    Actas Dermosifiliogr; 2017 Sep; 108(7):643-649. PubMed ID: 28385424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Unique Case of Cutaneous Larva Migrans Acquired Within the Province of Quebec and Successfully Treated With Topical Ivermectin.
    Smilga AS; Bujold J
    J Cutan Med Surg; 2018; 22(3):347-348. PubMed ID: 29373923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
    Trave I; Merlo G; Cozzani E; Parodi A
    Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19: The Ivermectin African Enigma.
    Guerrero R; Bravo LE; Muñoz E; Ardila EKG; Guerrero E
    Colomb Med (Cali); 2020 Dec; 51(4):e2014613. PubMed ID: 33795896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin.
    Bouchaud O; Houzé S; Schiemann R; Durand R; Ralaimazava P; Ruggeri C; Coulaud JP
    Clin Infect Dis; 2000 Aug; 31(2):493-8. PubMed ID: 10987711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.
    Gwee A; Duffull S; Zhu X; Tong SYC; Cranswick N; McWhinney B; Ungerer J; Francis J; Steer AC
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008886. PubMed ID: 33284799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pityriasis Folliculorum: Response to Topical Ivermectin.
    Darji K; Burkemper NM
    J Drugs Dermatol; 2017 Dec; 16(12):1290-1292. PubMed ID: 29240866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population.
    Heukelbach J; Winter B; Wilcke T; Muehlen M; Albrecht S; de Oliveira FA; Kerr-Pontes LR; Liesenfeld O; Feldmeier H
    Bull World Health Organ; 2004 Aug; 82(8):563-71. PubMed ID: 15375445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scabies: Diagnostic and Therapeutic Update.
    Richards RN
    J Cutan Med Surg; 2021; 25(1):95-101. PubMed ID: 32998532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous Larva Migrans.
    Leung AKC; Barankin B; Hon KLE
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):2-11. PubMed ID: 28078983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cutaneous larva migrans (creeping eruption) acquired in Germany].
    Müller-Stöver I; Richter J; Häussinger D
    Dtsch Med Wochenschr; 2010 Apr; 135(17):859-61. PubMed ID: 20408105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Systemic adverse reactions with ivermectin treatment of scabies].
    Sparsa A; Bonnetblanc JM; Peyrot I; Loustaud-Ratti V; Vidal E; Bédane C
    Ann Dermatol Venereol; 2006 Oct; 133(10):784-7. PubMed ID: 17072195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral ivermectin in scabies patients: a comparison with 1% topical lindane lotion.
    Madan V; Jaskiran K; Gupta U; Gupta DK
    J Dermatol; 2001 Sep; 28(9):481-4. PubMed ID: 11603388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety.
    Chaccour C; Hammann F; Rabinovich NR
    Malar J; 2017 Apr; 16(1):161. PubMed ID: 28434401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis.
    Perez-Garcia LA; Mejias-Carpio IE; Delgado-Noguera LA; Manzanarez-Motezuma JP; Escalona-Rodriguez MA; Sordillo EM; Mogollon-Rodriguez EA; Hernandez-Pereira CE; Marquez-Colmenarez MC; Paniz-Mondolfi AE
    Int J Antimicrob Agents; 2020 Aug; 56(2):106037. PubMed ID: 32479893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis.
    Padhy BM; Mohanty RR; Das S; Meher BR
    J Pharm Pharm Sci; 2020; 23():462-469. PubMed ID: 33227231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.
    Duthaler U; Suenderhauf C; Karlsson MO; Hussner J; Meyer Zu Schwabedissen H; Krähenbühl S; Hammann F
    Br J Clin Pharmacol; 2019 Mar; 85(3):626-633. PubMed ID: 30566757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.